Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q2 FY22 results · Jul–Sep 2021
Amrutanjan Health Care reported revenue from operations of ₹110.38 crore (up 19.8% from Q2 FY21) and net profit of ₹19.85 crore (down 15.7% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a standalone basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 110.38 | 92.11 | +19.8% | 78.21 | +41.1% |
| Other income | 4.29 | 4.05 | +5.8% | 2.74 | +56.5% |
| Total income | 114.67 | 96.16 | +19.2% | 80.95 | +41.7% |
| Profit before tax | 26.36 | 31.39 | −16.0% | 16.29 | +61.8% |
| Net profit for the period | 19.85 | 23.55 | −15.7% | 12.06 | +64.6% |
| EPS, basic (₹) | 6.79 | 8.06 | −15.8% | 4.12 | +64.8% |
| Net margin (%) | 18.0 | 25.6 | 15.4 |
Standalone
- Filed with BSE
- 09 Nov 2021, 17:23 IST
- Board meeting
- 09 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE